Skip to main content
Log in

Evaluation of in vitro and in vivo stability of the radiopharmaceutical [153Sm]Sm-EDTMP for biokinetics studies in bone metastases pain palliation care

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

The radiopharmaceutical [153Sm]Sm-EDTMP is administered for painful bone metastases with the standard dosage of 37 MBq/kg, without evaluation of patient individual characteristics. For a better dose estimate in vivo stability should be considered, because labelled and unlabelled samarium do not have the same metabolic pathway. We evaluated radiopharmaceutical in vitro stability, measuring the activity by beta and gamma spectrometry. Subsequently we verified in vivo stability on serial blood and urine samples. The percentage of the unlabelled radiopharmaceutical is high and, on the basis of radiochemical data as well as blood clearance and urine excretion, we calculated the main parameters for a preliminary biokinetic model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. De Vita VT Jr, Helman S, Rosemberg SA (1993) Cancer, principles and practice of oncology. Lippincott, Philadelphia-USA

    Google Scholar 

  2. Willis RW (1978) Tumours: basic principles and clinical aspects. Longman, New York

    Google Scholar 

  3. Serafini AN (2001) J Nucl Med 42:895

    CAS  Google Scholar 

  4. Abramson SD, Weissman G (1989) Clin Exp Rheumatol 7:163

    Google Scholar 

  5. Wolkert WA, Goeckeler WF, Ehrhardt GJ, Ketring AR (1991) J Nucl Med 32:174

    Google Scholar 

  6. Stöcklin G, Qaim SM, Rösch F (1995) Radiochim Acta 70/71:249

    Google Scholar 

  7. McEwan AJB (2000) Semin Radiat Oncol 10:103

    Article  CAS  Google Scholar 

  8. Cameron PJ, Klemp PFB, Martindale AA, Turner JH (1999) Nucl Med Commun 20:609

    Article  CAS  Google Scholar 

  9. Farhanghi M, Holmes RA, Volkert WA, Logan KW, Singh A (1992) J Nucl Med 33:1451

    CAS  Google Scholar 

  10. Brenner W, Kampen WU, Von Forstner C, Brümmer C, Zuhayra M, Muhle C, Czech N, Henze E (2001) J Nucl Med 42:1545

    CAS  Google Scholar 

  11. Annals of International Commission on Radiological Protection (ICRP) (1981) Publication 30, Part 3 including Addendum to Parts 1 and 2

  12. Gasiglia HT, Okada H (1995) J Radioanal Nucl Chem 199:29

    Google Scholar 

  13. Shargel L, Yu ABC (1980) Applied biopharmaceutics and pharmacokinetics. Appleton-Century-Crofts, New York

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Ridone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ridone, S., Arginelli, D., Inglese, E. et al. Evaluation of in vitro and in vivo stability of the radiopharmaceutical [153Sm]Sm-EDTMP for biokinetics studies in bone metastases pain palliation care. J Radioanal Nucl Chem 282, 287–291 (2009). https://doi.org/10.1007/s10967-009-0277-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-009-0277-2

Keywords

Navigation